Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
4
×
national top stories
new york blog main
new york top stories
4
×
clinical trials
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
depression
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
antidepressant
antisense oligonucleotide
anylam pharmaceuticals
assurex health
benzodiazepines
biogen
blackstone group
blackstone life sciences
blueprint medicines
What
genetic
4
×
new
approved
cancer
drug
fda
medicine
medicines
oks
ago
aims
akcea
alnylam
amyloidosis
attr
available
backed
battle
cause
centers
ceo
cut
debilitating
deeper
depression
disease
dna
drugs
epilepsy
event
fingerprint
genes
going
guesswork
guide
helps
links
major
making
marcio
Language
unset
Current search:
genetic
×
" national blog main "
×
" new york top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
